run_metadata: 42485
This data as json
| rowid | run.accession | experiment.accession | sample.accession | study.accession | bioproject | study.title | study.alias | study.type | study.abstract | study.attributes | study.PMIDs | sample.description | sample.title | sample.alias | sample.centername | sample.attributes | GEOsample.title | GEOsample.dataprocessing | GEOsample.source | GEOsample.treatmentprotocol | GEOsample.extractprotocol | GEOsample.growthprotocol | GEOsample.characteristics | GEOsample.accession | experiment.title | experiment.alias | experiment.library_name | experiment.design_description | experiment.library_construction_protocol | experiment.attributes | experiment.library_strategy | experiment.library_source | experiment.library_selection | experiment.library_layout | experiment.platform | experiment.instrument_model | experiment.spot_descriptor | experiment.study_ref | run.title | run.attributes | run.filename | run.semantic_name | run.total_bases | run.total_spots | run.alias | run.read_lengths | run.base_counts | run.r1_length | run.r2_length | run.r3_length | run.r4_length | run.Acount | run.Ccount | run.Gcount | run.Tcount | run.Ncount | run.experiment | run.pool_member | submission.accession | submission.srasource | submission.bioprojectsource | seqdetective.n_mates | seqdetective.mapping_rate.mate1 | seqdetective.mapping_rate.mate2 | seqdetective.nofeature_rate.mate1 | seqdetective.nofeature_rate.mate2 | seqdetective.sparsity.mate1 | seqdetective.sparsity.mate2 | seqdetective.pos_strand_rate.mate1 | seqdetective.pos_strand_rate.mate2 | seqdetective.readlen.mate1 | seqdetective.readlen.mate2 | seqdetective.judgement.mate1 | seqdetective.judgement.mate2 | seqdetective.judgement.reason | platform_family | instrument_generation | read_bias | selection_class | prep_kit | sc_or_bulk | tech_class | technology | tech_variant | submission.bioprojectsource.country | earliest_date | devstage_curation | devstage_curation_coarse | tissue_curation | tissue_curation_coarse |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42485 | SRR5639263 | SRX2877663 | SRS2249439 | SRP108529 | PRJNA388953 | c MYC drives neuroblastoma tumorigenesis and retinoic acid resistance in zebrafish [RNA Seq] | GSE99567 | Transcriptome Analysis | Neuroblastoma is an often intractable tumor that accounts for 15% of childhood cancer deaths. In addition to MYCN amplification in 20% of tumors 11% express high levels of c MYC MYC protein. To study this newly defined subgroup we have created a novel transgenic zebrafish model in which overexpression of MYC in the peripheral sympathetic nervous system drives early onset neuroblastoma. Overall design: RNA seq was performed on MYC and MYCN driven neuroblastoma tumors to determine chromatin accesibility in these cells | parent bioproject:PRJNA388873 | MYC 3 | GSM2646584 | tissue:EGFP+ neuroblastoma cells were harvested from tumor bearing MYC transgenic zebrafish.|cell type:EGFP+ neuroblasts | MYC 3 | Sequenced reads were trimmed for adaptor sequence and masked for low complexity or low quality sequence using cutadapt then mapped to dr7 whole genome using Tophat 2.0.11 without xxx splicing form calls Transcript abundance and differential expression were calculated with Cufflinks 2.2.1. FPKM values were used to normalize and quantify each transcripts Genome build: dr7 Supplementary files format and content: excel files include RPKM values for each Sample ... | EGFP+ neuroblastoma cells were harvested from tumor bearing MYC transgenic zebrafish. | Sorted EGFP+ cells were sorted then total RNA was extracted with Trizol LS. Total RNA was depleted of ribosomal RNA with the SMARTer Universal Low Input RNA Kit Clontech. Enriched mRNA was then applied to library preparation according to manufacturer’s protocol NEBNext Ultra. post repeated quality control for average DNA input size of 300 bp the samples were sequenced on a HiSeq Illumina sequencer with 2x100bp paired end reads. | EGFP+ neuroblastoma cells were harvested from tumor bearing MYCN and MYC transgenic zebrafish. Tumors were mechanically homogenized and EGFP+ cells were sorted directly into Trizol LS | cell type:EGFP+ neuroblasts | GSM2646584 | GSM2646584: MYC 3; Danio rerio; RNA Seq | GSM2646584 | 1 | Sorted EGFP+ cells were sorted then total RNA was extracted with Trizol LS. Total RNA was depleted of ribosomal RNA with the SMARTer Universal Low Input RNA Kit Clontech. Enriched mRNA was then applied to library preparation according to manufacturer’s protocol NEBNext Ultra. post repeated quality control for average DNA input size of 300 bp the samples were sequenced on a HiSeq Illumina sequencer with 2x100bp paired end reads. | GEO Accession:GSM2646584 | RNA-Seq | TRANSCRIPTOMIC | cDNA | PAIRED | ILLUMINA | Illumina HiSeq 2000 | SRP108529 | 20161116_MYC-3_MWZ3676_S3_R1_001.fastq.gz 20161116_MYC-3_MWZ3676_S3_R2_001.fastq.gz | fastq fastq | 9499251600.0 | 63328344.0 | GSM2646584 r1 | 0:75 1:75 | A:2600983566;C:2193461949;G:2224307535;T:2476379293;N:4119257 | 75 | 75 | 2600983566 | 2193461949 | 2224307535 | 2476379293 | 4119257 | SRX2877663 | SRS2249439 | SRA569347 | GEO | Oncology/Hematology, Boston Children's Hospital | 2 | 0.9202 | 0.92206 | 0.07816 | 0.07901 | 0.74612 | 0.75268 | 0.55199 | 0.54541 | 75 | 75 | B | B | biological fallback assumption | illumina | hiseq_era | full_length | rrna_depletion | nebnext | bulk | unknown | unknown | United States | 2017-06-01 | Undetermined | Undetermined | Cancer or Tumor | Cancer or Tumor |